Drugs Health Pharma

Embedded LEDs may aid future cancer immunotherapies

Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.

Read More
Drugs Pharma

Glenmark gets 2nd FDA nod for high blood sugar drug

Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.

Read More
Health Pharma

WHO maintains highest public alert on monkeypox

The WHO has maintained its highest form of alert, the Public Health Emergency of International Concern (PHEIC), on mpox, at its fourth meeting.

Read More
Drugs Medical Pharma

GE Healthcare recalls 688 medical systems, FDA says ‘most serious’

GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe.

Read More
Drugs Health Pharma

WHO to hold emergency meeting on Marburg virus outbreak

WHO to hold emergency meeting on Marburg virus outbreak

Read More
Drugs Health Medical Pharma

Novavax to supply 1.5m COVID-19 vaccine doses to US

Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.

Read More
Climate Health Pharma

Hong Kong culls all pigs tested positive for African swine fever

Authorities in Hong Kong culled all the pigs that tested positive for African swine fever in the Ta Kiu Ling farm, according to.

Read More
Health Medical Pharma

Excessive salt in your diet may harm immune system, scientists say

Too much salt in your diet may be bad for your blood pressure and the cardiovascular system, but global research done by a.

Read More
Drugs Medical Pharma

Globus Medical buys NuVasive in all-stock for $3.1 billion

Globus Medical, a US-based publicly traded medical device company making products to treat musculoskeletal disorders, acquired NuVasive in an all-stock deal worth $3.1.

Read More
Drugs Pharma

FDA puts on hold Blueprint Medicines’ clinical trial for solid cancers

The USFDA has put on hold Blueprint Medicines Corporation's clinical trial of BLU-222 due to visual adverse events seen in some patients, according.

Read More
X